New Market Report: Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Jan. 15, 2011 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Addiction Control Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Addiction Control market. The report identifies the key trends shaping and driving the global Addiction Controlmarket. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Addiction Control sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
GlobalData estimated the addiction control market to be worth $4,206m in 2009, and forecast it to grow at 4.7% annually for the next eight years to reach $6,052m by 2017. The addiction control market has relatively high growth, as the market has relatively fewer treatment options so that physicians are not left with many options, which translates into a high prescription rate of existing branded and generic products. In addition, the successful launch of NicVAX which is currently in Phase III may significantly stimulate market growth in near future. The global addiction control market in 2009 primarily consisted of drug classes which included dopamaine and norepinephrine reuptake inhibitors and opoid receptor antagonists. However, the low treatment seeking rate and patent expiry of the current major marketed products such as Suboxone/Subutex, Campral, Nicotine replacement therapies (NRTs) and Zyban will act as a barrier to market growth.

Scope

The report provides information on the key drivers and challenges of the Addiction Control market. Its scope includes:

* Annualized global addiction control market revenues data from 2001 to 2009, forecast for seven years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Dopamine and norepinephrine reuptake inhibitors, Dopamine receptor antagonists, Acetylcholinesterase inhibitors, Serotonin-norepinephrine reuptake inhibitors, vaccines eliciting anti-nicotine antibody production, Nicotinic Acetylcholine (nACh) Agonists, NK1 receptor antagonist and others.
* Analysis of the current and future competition in the global Addiction Control market, covering key market players like Pfizer, Glaxosmithkline, Eli lilly and company, Alkermes, Merck, Nabi Biopharmaceuticals, Titan pharmaceuticals, H.Lundbeck, Celtic pharmaceuticals, Novartis and Cytos pharmaceuticals.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Addiction Control therapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Addiction Control market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Addiction Control market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Addiction Control market landscape? - Identify, understand and capitalize.



For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/109277_addiction_control_thera...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.